OneFlorida Cancer Control Alliance Minority Education Program
The OneFlorida Cancer Control Alliance recently sent out a call for applications for its Cancer Prevention and Control Pragmatic Trials and Implementation Science Minority Education Program. The deadline for the competitive Letter of Intent was Oct. 10. The mandatory Innovation Studio for Successful Applicants is on Wednesday, Nov. 12 and the deadline for the full proposal is Thursday, Feb. 12.
The purpose of the OneFlorida Cancer Control Alliance’s Minority Education Program is to promote diversity in cancer prevention and control research by providing developmental support for junior faculty who are members of underrepresented groups. Our particular focus is on the following racial and ethnic groups who have been shown to be underrepresented in biomedical research: African Americans, Hispanic Americans, American Indians, Alaska Natives, Native Hawaiians, and other Pacific Islanders.
Participants would receive:
- $25,000 award to fund research
- one-on-one mentorship from a senior faculty member at the University of Florida, Florida State University, or the University of Miami
- support for study protocol and research coordination
Training Program Description:
The Pragmatic Clinical Trials & Implementation Science-Minority Education Program (PCTIS-MEP) is a mentored research experience where a junior faculty member and one of their students will receiving mentoring from a senior faculty member affiliated with the University of Florida (UF), Florida State University (FSU), or University of Miami (UM) Clinical and Translational Science Institutes (CTSIs) or Cancer Centers to conduct secondary data analyses that could lead to a pragmatic clinical trial or implementation science study in the area of cancer prevention and control. Pilot pragmatic clinical trials or implementation science studies are also supported through this mechanism.
For the purpose of this training program, we are adopting the following definition of implementation science based on the NIH Grant information Program Announcement PAR 13-055: Implementation is the use of strategies to adopt and integrate evidence-based health interventions and change practice patterns within specific settings. Note that implementation is different from “dissemination,” which is the targeted distribution of information and intervention materials to a specific public health or clinical practice audience. This training program focuses on implementation science, with specific focus on projects that examine factors that influence the uptake, adaptation, and adoption of evidence-based health interventions for population health.
We are adopting the following definition of pragmatic trials based on the NIH Grant Information Program Announcement PAR 13-366: Pragmatic trials “evaluate the effectiveness of interventions or therapies in research design to maximize applicability of the trial’s results to routine healthcare conditions.”
In addition, the junior faculty and their student will be required to participate in two 3-credit online courses offered through the UF Department of Health Outcomes and Policy (GMS 6852: Community-Engaged Research and Implementation Science and GMS 6853: Applied Topics in Pragmatic Clinical Trials and Implementation Science).
The goals of this program are to:
(1) Promote diversity among biomedical research scientists;
(2) Enhance and develop new opportunities for diversity-related research in the area of cancer prevention and control with a particular focus on pragmatic clinical trials and implementation science; and
(3) Create synergies and collaboration with cancer prevention and control scientists throughout Florida.
For the 2014-2015 grant cycle we are interested in applications that:
(1) Use secondary health care claims and encounter data for individuals receiving Medicaid or using the Florida Cancer Data System (FCDS) registry to conduct analyses that can be used to design pragmatic clinical trials and/or implementation science studies; or
(2) Pilot projects testing interventions within health care settings to improve cancer prevention and/or control.
We are particularly interested in cancer control and prevention-related topics that align with the Institute of Medicine (IOM) priorities related to: engaged patients and shared decision-making with their clinicians; interventions to promote the uptake of evidence-based interventions in diverse practice settings, comparative effectiveness research related to cancer prevention and control, and the use of health information technology to enhance the quality and delivery of cancer-related care.
The Minority Education Program will provide assistance in finding and accessing appropriate secondary data, including publicly available data such as BRFSS, data managed by the Florida Cancer Data System (FCDS) registry, or research data housed at one of the OneFlorida Cancer Control Alliance partners as well as IRB submission support.
For more information, contact Folakemi T. Odedina, Ph.D., director of the Pragmatic Clinical Trials & Implementation Science Minority Education Program, at firstname.lastname@example.org.
For more information about eligibility requirements, program descriptions and contact information, click here.